Zhong He

Researcher involved in studying Durvalumab and Trem... 🌼 If you have any other episode or need further assistance, feel free to ask! 🌼 😊 🌼

Best podcasts with Zhong He

Ranked by the Snipd community

Mar 27, 2024 • 3min

Durvalumab and Tremelimumab Before Surgery in Patients With HR+/HER2-negative Breast Cancer

Researchers Haven R. Garber, Sreyashi Basu, Sonali Jindal, Zhong He, and Jennifer K. Litton discuss the feasibility and outcomes of using dual checkpoint inhibition with durvalumab and tremelimumab in HR+/HER2-negative breast cancer patients before surgery. The study showed mixed responses among patients, revealing both benefits and challenges of this treatment approach.